#162135

Jurkat T cell Ca2+ Lantern-NLuc cell line

Cat. #162135

Jurkat T cell Ca2+ Lantern-NLuc cell line

Cat. #: 162135

Sub-type: Continous

Availability: 8-10 weeks

Organism: Human

Disease: Cancer

Model: Genetically modified cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ann-Marie Chacko/Sven H. Petersen

Institute: National University of Singapore

Tool Details
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Jurkat T cell Ca2+ Lantern-NLuc cell line
  • Cancer: Blood cancer
  • Tool sub type: Continous
  • Parental cell: Jurkat
  • Organism: Human
  • Disease: Cancer
  • Morphology: Lymphoblast
  • Growth properties: Suspension
  • Model: Genetically modified cell line
  • Description: Geneteically modified T cell-acute lymphoblastic leukaemia (T-ALL)
  • Biosafety level: 2

Handling

  • Format: Frozen
  • Growth medium: RPMI + 10% FBS
  • Mycoplasma free: Yes